Company / Return on Assets (ROA)
CRESCENT BIOPHARMA, INC. Return on Assets (ROA) History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-64.1%
FY2025
5-year range
-64.1% / 6.4%
FY2021-FY2025
Trend
-545.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) changed -545% YoY in FY2025, a notable deviation from the 4-year average annual change of -236%.
Based on SEC 10-K filings.
-64.1% in FY2025 with a 10-year CAGR of -42.2%.
Declined from -26.2% to -64.1% over the past 9 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -42.2pp
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 545.1% year-over-year.
- Peak return on assets (roa) was recorded in FY2014.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -64.1% | -545.1% |
| FY2017 | -9.9% | +62.2% |
| FY2016 | -26.2% | -19.9% |
| FY2015 | -21.9% | -442.9% |
| FY2014 | 6.4% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026